株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

アジア太平洋地域における出生前および新生児の遺伝子検査市場

Asia Pacific Prenatal & Newborn Genetic Testing Market to 2027 - Regional Analysis and Forecasts by Product, Disease Indication, Technology, End User and Geography

発行 The Insight Partners 商品コード 910926
出版日 ページ情報 英文 281 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.53円で換算しております。
アジア太平洋地域における出生前および新生児の遺伝子検査市場 Asia Pacific Prenatal & Newborn Genetic Testing Market to 2027 - Regional Analysis and Forecasts by Product, Disease Indication, Technology, End User and Geography
出版日: 2019年11月18日 ページ情報: 英文 281 Pages
概要

当レポートはアジア太平洋地域における出生前および新生児の遺伝子検査市場について調査しており、市場機会、今後の動向、成長および阻害要因、タイプ・適応症・技術・エンドユーザー・国別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • The Insight Partners調査レポートのガイダンス
  • 市場セグメント

第2章 重点

第3章 調査方法

  • 調査範囲
  • 二次調査
  • 一次調査

第4章 市況

  • 概要
  • PEST分析

第5章 主要産業力学

  • 主な市場成長要因
  • 主な市場阻害要因
  • 主な市場機会
  • 今後の動向
  • 影響分析

第6章 アジア太平洋地域の分析

  • 市場収益予測および分析
  • 主要企業の実績
  • インドの超音波スクリーニング市場

第7章 市場分析および予測:タイプ別

  • 概要
  • 市場シェア
  • 診断
  • スクリーニング

第8章 市場分析および予測:適応症別

  • 概要
  • 市場シェア
  • 嚢胞性線維症
  • 鎌状赤血球貧血
  • ダウン症候群
  • フェニルケトン尿症
  • 習慣性流産
  • 抗リン脂質症候群(APS)
  • その他

第9章 市場分析および予測:技術別

  • 概要
  • 市場シェア
  • 分光光度計
  • ポリメラーゼ連鎖反応
  • 蛍光in-situハイブリダイゼーション
  • アレイ比較ゲノムハイブリダイゼーション
  • その他

第10章 市場分析および予測:エンドユーザー

  • 概要
  • 市場シェア
  • 病院および診療所
  • 診断センター
  • その他

第11章 市場分析および予測:国別

  • セグメント別
  • 国別

第12章 競合情勢

  • 概要
  • 企業比較分析
  • 市場参入企業の成長戦略
  • 有機的開発
  • 無機的開発

第13章 企業プロファイル

  • LifeCell
  • Quest Diagnostics Incorporated
  • Medgenome
  • Eurofins Scientific
  • Metropolis India
  • SRL Diagnostics
  • Sandor Lifesciences Pvt. Ltd.
  • PerkinElmer, Inc.
  • Natera, Inc.
  • Laboratory Corporation Of America Holdings (Sequenom)
  • Genes2Me LLP
  • Illumina, Inc.

章14章 付録

  • The Insight Partnersについて
  • 用語集
図表

LIST OF TABLES

  • Table 1. China Screening Market, Volume And Forecast To 2027, By Type (Units)
  • Table 2. China Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
  • Table 3. Japan Screening Market, Volume And Forecast To 2027, By Type (Units)
  • Table 4. Japan Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
  • Table 5. India Screening Market, Volume And Forecast To 2027, By Type (Units)
  • Table 6. India Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
  • Table 7. Thailand Screening Market, Volume And Forecast To 2027, By Type (Units)
  • Table 8. Thailand Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
  • Table 9. Malaysia Screening Market, Volume And Forecast To 2027, By Type (Units)
  • Table 10. Malaysia Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
  • Table 11. Singapore Screening Market, Volume And Forecast To 2027, By Type (Units)
  • Table 12. Singapore Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
  • Table 13. Indonesia Screening Market, Volume And Forecast To 2027, By Type (Units)
  • Table 14. Indonesia Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
  • Table 15. Pakistan Screening Market, Volume And Forecast To 2027, By Type (Units)
  • Table 16. Pakistan Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
  • Table 17. Bangladesh Screening Market, Volume And Forecast To 2027, By Type (Units)
  • Table 18. Bangladesh Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
  • Table 19. Nepal Screening Market, Volume And Forecast To 2027, By Type (Units)
  • Table 20. Nepal Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
  • Table 21. Sri Lanka Screening Market, Volume And Forecast To 2027, By Type (Units)
  • Table 22. Sri Lanka Diagnostics Market, Volume And Forecast To 2027, By Type (Units)
  • Table 23. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 24. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 25. Asia Pacific Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 26. Asia Pacific Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 27. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 28. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 29. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 30. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 31. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 32. China Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 33. China Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 34. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 35. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 36. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 37. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 38. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 39. Japan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 40. Japan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 41. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 42. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 43. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 44. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 45. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 46. India Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 47. India Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 48. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 49. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 50. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 51. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 52. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 53. Pakistan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 54. Pakistan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 55. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 56. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 57. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 58. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 59. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 60. Sri Lanka Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 61. Sri Lanka Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 62. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 63. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 64. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 65. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 66. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 67. Bangladesh Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 68. Bangladesh Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 69. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 70. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 71. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 72. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 73. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 74. Nepal Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 75. Nepal Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 76. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 77. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 78. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 79. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 80. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 81. Indonesia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 82. Indonesia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 83. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 84. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 85. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 86. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 87. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 88. Singapore Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 89. Singapore Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 90. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 91. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 92. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 93. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 94. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 95. Malaysia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 96. Malaysia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 97. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 98. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 99. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 100. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
  • Table 101. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
  • Table 102. Thailand Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 103. Thailand Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
  • Table 104. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
  • Table 105. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
  • Table 106. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • Table 107. Organic Developments Done By Companies
  • Table 108. Inorganic Developments Done By Companies
  • Table 109. Glossary of Terms, Prenatal And Newborn Genetic Testing Market

LIST OF FIGURES

  • Figure 1. Prenatal And Newborn Genetic Testing Market Segmentation
  • Figure 2. India Prenatal And Newborn Genetic Testing Market, Revenue (US$ Mn),, 2018 & 2027
  • Figure 3. Asia Pacific Prenatal And Newborn Genetic Testing Market By Product, Market Share (%), 2018
  • Figure 4. Asia Pacific Prenatal And Newborn Genetic Testing Market By Disease Indication, Market Share (%), 2018
  • Figure 5. Asia Pacific Prenatal And Newborn Genetic Testing Market By Technology, Market Share (%), 2018
  • Figure 6. Asia Pacific Prenatal And Newborn Genetic Testing Market By End User, Market Share (%), 2018
  • Figure 7. Asia Pacific PEST Analysis
  • Figure 8. Prenatal And Newborn Genetic Testing Market: Impact Analysis of Driver And Restraints
  • Figure 9. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue Forecast And Analysis, 2018-2027
  • Figure 10. Nuchal Translucency Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 11. Fetal Nasal Bone Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 12. Tricuspid Regurgitation Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 13. Average Selling Price for Prenatal and Newborn Genetic Tests in China
  • Figure 14. Average Selling Price for Prenatal and Newborn Genetic Tests in Japan
  • Figure 15. Average Selling Price for Prenatal and Newborn Genetic Tests in India
  • Figure 16. Average Selling Price for Prenatal and Newborn Genetic Tests in Thailand
  • Figure 17. Average Selling Price for Prenatal and Newborn Genetic Tests in Malaysia
  • Figure 18. Average Selling Price for Prenatal and Newborn Genetic Tests in Singapore
  • Figure 19. Average Selling Price for Prenatal and Newborn Genetic Tests in Indonesia
  • Figure 20. Average Selling Price for Prenatal and Newborn Genetic Tests in Pakistan
  • Figure 21. Average Selling Price for Prenatal and Newborn Genetic Tests in Bangladesh
  • Figure 22. Average Selling Price for Prenatal and Newborn Genetic Tests in Nepal
  • Figure 23. Average Selling Price for Prenatal and Newborn Genetic Tests in Sri Lanka
  • Figure 24. Asia Pacific Prenatal and Newborn Genetic Testing Market Share, by Product, in Terms of Revenue, 2018 & 2027 (%)
  • Figure 25. Diagnostics Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 26. Amniocentesis Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 27. Chorionic Villus Sampling Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 28. Cytogenetic and Pharmacogenetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 29. Screening Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 30. Maternal Serum Screening Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 31. Noninvasive Prenatal Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 32. Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Disease Indication, 2018 & 2027 (%)
  • Figure 33. Cystic Fibrosis Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 34. Sickle Cell Anemia Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 35. Down syndrome Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 36. Phenylketonuria Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 37. Recurrent Pregnancy Loss Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 38. Antiphospholipid Syndrome Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 39. Other Diseases Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 40. Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Technology, 2018 & 2027 (%)
  • Figure 41. Asia Pacific Spectrophotometer Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 42. Polymerase Chain Reaction Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 43. Fluorescence In-Situ Hybridization Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 44. Array Comparative Genomic Hybridization Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 45. Others Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 46. Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by End User, 2018 & 2027 (%)
  • Figure 47. Asia Pacific Hospitals and Clinics Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 48. Diagnostic Centers Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 49. Other End User Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 50. Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue Overview, By Country, 2018 (US$ MN)
  • Figure 51. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 52. Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue and Forecast to 2027, By Country (%)
  • Figure 53. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 54. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 55. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 56. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 57. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 58. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 59. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 60. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 61. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 62. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 63. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
  • Figure 64. Comparative Company Analysis
  • Figure 65. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00006470

The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 1,679.956 Mn in 2027 from US$ 630.914 in 2018. The market is estimated to grow with a CAGR of 11.6% from 2019-2027.

The key factors responsible for the growth of the market in Asia Pacific are rising burden of genetic diseases among infants, increasing fertility rates and developing healthcare scenario with rising awareness among populace regarding the benefits of prenatal testing. On the other hand, use of digital microfluidics in newborn testing is likely to be a prevalent trend in the future years. Soaring birth rates among developing economies are responsible for fueling global baby boom. However, the rising birth rate also contributes to rising birth defects and infants suffering from several genetic diseases. According to a report published by Bill and Melinda Gates Foundation in 2018, there are almost 250 babies born every minute around the globe. Moreover, according to the Centers for Disease Control and Prevention, the fertility rates for Hispanic women was highest in 2017 among Hispanic women with 67.1 births per 1,000 women.

Asian countries such as India and China also have high fertility rates due to factors such as effects of religion, inadequate supply of family welfare services, poverty, and others. According to the World Bank in 2016, the fertility rates in India were reported to be 2.23 births per women as compared to 1.80 in the United States and 1.62 in China. Moreover, neighboring countries, such as Pakistan also have alarming rates of fertility. In 2016, the birth rate in Pakistan was reported to be 3.48 births per woman as per the World Bank data. However, the birthrate in India has successfully reduced its high fertility rate, but still is high as compared to other developed nations. According to the United Nations (UN) report published on June 2019, the fertility rate has reduced to 2.1. Therefore, by 2050 additional 273 million people will be added to India's population. The increasing number of parturient women across the world are thus likely to create increasing demand for prenatal and newborn genetic tests across the globe leading to the growth of the market.

The Asia Pacific prenatal and newborn genetic testing market, based on the disease indication was segmented into cystic fibrosis, sickle cell anemia, downs syndrome, phenylketonuria, recurrent pregnancy loss, and Antiphospholipid syndrome, and other diseases. In 2018, Down syndrome segment held the largest share of the market, by disease indication. The highest share of Down syndrome attributes to the high prevalence of this genetic abnormality among fetuses and availability of multiple tests for its screening and diagnostics. However, the sickle cell anemia segment is expected to grow at the fastest rate during the coming year.

Some of the major primary and secondary sources for prenatal and newborn genetic testing included in the report are Food & Drug Administration (FDA), Indian Institutes of Technology (IITs), International Trade Administration (ITA), Japan Society of Obstetrics and Gynecology (JSOG), Council of Scientific and Industrial Research (cSIR), Pakistan Down Syndrome Association (PDSA) and others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the prenatal & newborn genetic testing market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the regional prenatal & newborn genetic testing market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Product
    • 1.3.2 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Disease Indication
    • 1.3.3 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Technology
    • 1.3.4 Asia Pacific Prenatal and Newborn Genetic Testing Market - By End User
    • 1.3.5 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Country

2. Asia Pacific Prenatal and Newborn Genetic Testing Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Prenatal And Newborn Genetic Testing- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Asia Pacific - PEST Analysis
  • 4.3 Expert Opinions

5. Asia Pacific Prenatal and Newborn Genetic Testing Market - Key Industry Dynamics

  • 5.1 Key Drivers
    • 5.1.1 Burden of Genetic Diseases in India
    • 5.1.2 Increasing Fertility Rate
  • 5.2 Key Restraints
    • 5.2.1 Risks Associated with Prenatal Testing
  • 5.3 Key Opportunities
    • 5.3.1 Development of Policies for Treatment of Rare Diseases
  • 5.4 Future Trends
    • 5.4.1 Digital Microfluidics as New Opportunity Area for Newborn Screening
  • 5.5 Impact Analysis

6. Prenatal And Newborn Genetic Testing Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue Forecast And Analysis
  • 6.2 Market Positioning
  • 6.3 India Ultrasound Screening Market
    • 6.3.1 Nuchal Translucency
      • 6.3.1.1 Overview
      • 6.3.1.2 Nuchal Translucency Market, revenue and forecast to 2027 (US$ Mn)
    • 6.3.2 Fetal Nasal Bone Assessment
      • 6.3.2.1 Overview
      • 6.3.2.2 Fetal Nasal Bone Assessment Market, revenue and forecast to 2027 (US$ Mn)
    • 6.3.3 Tricuspid Regurgitation
      • 6.3.3.1 Overview
      • 6.3.3.2 Tricuspid Regurgitation Market, revenue and forecast to 2027 (US$ Mn)
  • 6.4 Pricing Analysis
  • 6.5 Asia Pacific Prenatal And Newborn Genetic Testing Market, By Country, Volume And Forecast To 2027
    • 6.5.1 China Screening Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.2 China Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.3 Japan Screening Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.4 Japan Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.5 India Screening Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.6 India Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.7 Thailand Screening Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.8 Thailand Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.9 Malaysia Screening Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.10 Malaysia Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.11 Singapore Screening Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.12 Singapore Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.13 Indonesia Screening Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.14 Indonesia Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.15 Pakistan Screening Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.16 Pakistan Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.17 Bangladesh Screening Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.18 Bangladesh Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.19 Nepal Screening Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.20 Nepal Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.21 Sri Lanka Screening Market, Volume And Forecast to 2027, By Type (Units)
    • 6.5.22 Sri Lanka Diagnostics Market, Volume And Forecast to 2027, By Type (Units)

7. Prenatal And Newborn Genetic Testing Market, By Product, Analysis And Forecast To 2027

  • 7.1 Overview
  • 7.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Product, 2018 & 2027 (%)
  • 7.3 Diagnostics
    • 7.3.1 Overview
    • 7.3.2 Diagnostics Market, revenue and forecast to 2027 (US$ Mn)
    • 7.3.3 Amniocentesis
      • 7.3.3.1 Overview
      • 7.3.3.2 Amniocentesis Market, revenue and forecast to 2027 (US$ Mn)
    • 7.3.4 Chorionic Villus Sampling
      • 7.3.4.1 Overview
      • 7.3.4.2 Chorionic Villus Sampling Market, revenue and forecast to 2027 (US$ Mn)
    • 7.3.5 Cytogenetic and Pharmacogenetic Testing
      • 7.3.5.1 Overview
      • 7.3.5.2 Cytogenetic and Pharmacogenetic Testing Market, revenue and forecast to 2027 (US$ Mn)
  • 7.4 Screening
    • 7.4.1 Overview
    • 7.4.2 Screening Market, revenue and forecast to 2027 (US$ Mn)
    • 7.4.3 Maternal Serum Screening
      • 7.4.3.1 Overview
      • 7.4.3.2 Maternal Serum Screening Market, revenue and forecast to 2027 (US$ Mn)
    • 7.4.4 Noninvasive Prenatal Testing
      • 7.4.4.1 Overview
      • 7.4.4.2 Noninvasive Prenatal Testing Market, revenue and forecast to 2027 (US$ Mn)

8. Prenatal And Newborn Genetic Testing Market Analysis And Forecast To 2027 - Disease Indication

  • 8.1 Overview
  • 8.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Disease Indication, 2018 & 2027 (%)
  • 8.3 Cystic Fibrosis
    • 8.3.1 Overview
    • 8.3.2 Cystic Fibrosis Market, Revenue And Forecast to 2027 (US$ Mn)
  • 8.4 Sickle Cell Anemia
    • 8.4.1 Overview
    • 8.4.2 Sickle Cell Anemia Market, revenue and forecast to 2027 (US$ Mn)
  • 8.5 Down Syndrome
    • 8.5.1 Overview
    • 8.5.2 Down syndrome Market, revenue and forecast to 2027 (US$ Mn)
  • 8.6 Phenylketonuria
    • 8.6.1 Overview
    • 8.6.2 Phenylketonuria Market, revenue and forecast to 2027 (US$ Mn)
  • 8.7 Recurrent Pregnancy Loss
    • 8.7.1 Overview
    • 8.7.2 Recurrent Pregnancy Loss Market, revenue and forecast to 2027 (US$ Mn)
  • 8.8 Antiphospholipid Syndrome
    • 8.8.1 Overview
    • 8.8.2 Antiphospholipid Syndrome Market, revenue and forecast to 2027 (US$ Mn)
  • 8.9 Other Diseases
    • 8.9.1 Overview
    • 8.9.2 Other Diseases Market, revenue and forecast to 2027 (US$ Mn)

9. Prenatal And Newborn Genetic Testing Market Analysis And Forecast To 2027 - Technology

  • 9.1 Overview
  • 9.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Technology, 2018 & 2027 (%)
  • 9.3 Spectrophotometer
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific Spectrophotometer Market, Revenue And Forecast To 2027 (US$ Mn)
  • 9.4 Polymerase Chain Reaction
    • 9.4.1 Overview
    • 9.4.2 Polymerase Chain Reaction Market, revenue and forecast to 2027 (US$ Mn)
  • 9.5 Fluorescence In-situ Hybridization
    • 9.5.1 Overview
    • 9.5.2 Fluorescence in-situ Hybridization Market, revenue and forecast to 2027 (US$ Mn)
  • 9.6 Array Comparative Genomic Hybridization Market
    • 9.6.1 Overview
    • 9.6.2 Array Comparative Genomic Hybridization Market, revenue and forecast to 2027 (US$ Mn)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others Market, revenue and forecast to 2027 (US$ Mn)

10. Prenatal And Newborn Genetic Testing Market Analysis And Forecast To 2027 - End User

  • 10.1 Overview
  • 10.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by End User, 2018 & 2027 (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Hospitals and Clinics Market, Revenue And Forecast To 2027 (US$ Mn)
  • 10.4 Diagnostic Centers
    • 10.4.1 Overview
    • 10.4.2 Diagnostic Centers Market, revenue and forecast to 2027 (US$ Mn)
  • 10.5 Other End Users
    • 10.5.1 Overview
    • 10.5.2 Other End Users Market, Revenue And Forecast To 2027 (US$ Mn)

11. Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 - Geographical Analysis

  • 11.1 Asia Pacific Prenatal And Newborn Genetic Testing Market
    • 11.1.1 Overview
    • 11.1.2 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
    • 11.1.3 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
    • 11.1.4 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
      • 11.1.4.1 Asia Pacific Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.1.4.2 Asia Pacific Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
    • 11.1.5 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
    • 11.1.6 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
    • 11.1.7 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
  • 11.2 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue and Forecast to 2027, By Country (%)
    • 11.2.1 China Prenatal And Newborn Genetic Testing Market
      • 11.2.1.1 China Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
      • 11.2.1.2 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
      • 11.2.1.3 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
        • 11.2.1.3.1 China Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
        • 11.2.1.3.2 China Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.2.1.4 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
      • 11.2.1.5 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
      • 11.2.1.6 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
    • 11.2.2 Japan Prenatal And New born Genetic Testing Market
      • 11.2.2.1 Japan Prenatal And New Born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
      • 11.2.2.2 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
      • 11.2.2.3 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
        • 11.2.2.3.1 Japan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
        • 11.2.2.3.2 Japan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.2.2.4 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
      • 11.2.2.5 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
      • 11.2.2.6 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
    • 11.2.3 India Prenatal And New born Genetic Testing Market
      • 11.2.3.1 India Prenatal and New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
      • 11.2.3.2 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
      • 11.2.3.3 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
        • 11.2.3.3.1 India Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
        • 11.2.3.3.2 India Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.2.3.4 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
      • 11.2.3.5 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
      • 11.2.3.6 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
    • 11.2.4 Pakistan Prenatal And New born Genetic Testing Market
      • 11.2.4.1 Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
      • 11.2.4.2 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
      • 11.2.4.3 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
        • 11.2.4.3.1 Pakistan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
        • 11.2.4.3.2 Pakistan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.2.4.4 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
      • 11.2.4.5 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
      • 11.2.4.6 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
    • 11.2.5 Sri Lanka Prenatal And New born Genetic Testing Market
      • 11.2.5.1 Sri Lanka Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
      • 11.2.5.2 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
      • 11.2.5.3 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
        • 11.2.5.3.1 Sri Lanka Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
        • 11.2.5.3.2 Sri Lanka Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.2.5.4 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
      • 11.2.5.5 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
      • 11.2.5.6 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
    • 11.2.6 Bangladesh Prenatal And New born Genetic Testing Market
      • 11.2.6.1 Bangladesh Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
      • 11.2.6.2 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
      • 11.2.6.3 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
        • 11.2.6.3.1 Bangladesh Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
        • 11.2.6.3.2 Bangladesh Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.2.6.4 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
      • 11.2.6.5 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
      • 11.2.6.6 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
    • 11.2.7 Nepal Prenatal And New born Genetic Testing Market
      • 11.2.7.1 Nepal Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
      • 11.2.7.2 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
      • 11.2.7.3 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
        • 11.2.7.3.1 Nepal Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
        • 11.2.7.3.2 Nepal Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.2.7.4 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
      • 11.2.7.5 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
      • 11.2.7.6 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
    • 11.2.8 Indonesia Prenatal And Newborn Genetic Testing Market
      • 11.2.8.1 Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
      • 11.2.8.2 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
      • 11.2.8.3 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
        • 11.2.8.3.1 Indonesia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
        • 11.2.8.3.2 Indonesia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.2.8.4 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
      • 11.2.8.5 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
      • 11.2.8.6 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
    • 11.2.9 Singapore Prenatal And Newborn Genetic Testing Market
      • 11.2.9.1 Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
      • 11.2.9.2 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
      • 11.2.9.3 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
        • 11.2.9.3.1 Singapore Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
        • 11.2.9.3.2 Singapore Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.2.9.4 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
      • 11.2.9.5 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
      • 11.2.9.6 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
    • 11.2.10 Malaysia Prenatal And Newborn Genetic Testing Market
      • 11.2.10.1 Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
      • 11.2.10.2 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
      • 11.2.10.3 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
        • 11.2.10.3.1 Malaysia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
        • 11.2.10.3.2 Malaysia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.2.10.4 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
      • 11.2.10.5 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
      • 11.2.10.6 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
    • 11.2.11 Thailand Prenatal And Newborn Genetic Testing Market
      • 11.2.11.1 Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
      • 11.2.11.2 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
      • 11.2.11.3 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
        • 11.2.11.3.1 Thailand Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
        • 11.2.11.3.2 Thailand Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
      • 11.2.11.4 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
      • 11.2.11.5 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
      • 11.2.11.6 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)

12. Prenatal And Newborn Genetic Testing Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Comparative Company Analysis
  • 12.3 Growth Strategies Done by the Companies in the Market, (%)
  • 12.4 Organic Developments
    • 12.4.1 Overview
  • 12.5 Inorganic Developments
    • 12.5.1 Overview

13. Prenatal And Newborn Genetic Testing Market - Key Company Profiles

  • 13.1 LifeCell
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Financial Overview
    • 13.1.4 Product Portfolio
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Quest Diagnostics Incorporated
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Financial Overview
    • 13.2.4 Product Portfolio
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Medgenome
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Financial Overview
    • 13.3.4 Product Portfolio
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Eurofins Scientific
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Financial Overview
    • 13.4.4 Product Portfolio
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Metropolis India
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Financial Overview
    • 13.5.4 Product Portfolio
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 SRL Diagnostics
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Financial Information
    • 13.6.4 Product Portfolio
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Sandor Lifesciences Pvt. Ltd.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Financial Overview
    • 13.7.4 Product Portfolio
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 PerkinElmer, Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Financial Overview
    • 13.8.4 Product Portfolio
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Natera, Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Financial Overview
    • 13.9.4 Product Portfolio
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Laboratory Corporation Of America Holdings (Sequenom)
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Financial Overview
    • 13.10.4 Product Portfolio
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Genes2Me LLP
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Financial Overview
    • 13.11.4 Product Portfolio
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Illumina, Inc.
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Financial Overview
    • 13.12.4 Product Portfolio
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms